PHARMACOLOGICAL PROPERTIES OF CEPHALOSPORINS

被引:20
作者
CHRIST, W
机构
[1] Institut für Arzneimittel des Bundesgesundheitsamtes, Berlin 65, W-1000
关键词
D O I
10.1007/BF01645535
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The cephalosporins differ in the substituents attached at the 3 and/or 7 positions of the molecule. Very schematically, substitution at C3 mainly modifies the overall pharmacokinetic properties whereas substitution at position 7 influences the antibacterial characteristics. When using the more common "generation" system for classification, three generations can be distinguished on the basis of their antibacterial spectrum, potency, and their stability to beta-lactamases. The first generation cephalosporins have similar antibacterial and pharmacokinetic characteristics. C3-esterfied cephalosporins (e.g. cephalothin and cephapirin) are significantly metabolized. The so-called second generation cephalosporins exhibit only minor differences with respect to the pharmacokinetic properties in contrast to the third generation cephalosporins. The apparent volumes of distribution of most cephalosporins range between seven and 20 1, indicating that they mainly stay in the extracellular space. Plasma protein binding is variable from compound to compound. Generally, the major route of elimination of most cephalosporins is via the kidney except for cefoperazone and ceftriaxone which are both excreted to a large extent by the biliary route. With the exception of cefonicid, cefotetan and ceftriaxone, which have longer elimination half-lives (i.e. 4.5, 3.5 and around eight hours), all other cephalosporins have a half-life ranging from 0.5 to 2.5 hours. The pattern of adverse reactions is comparable for all the cephalosporins although there are slight differences in both the incidence and the type of reactions. The major categories of adverse reactions are gastrointestinal, dermatologic, hypersensitivity, haematologic, hepatic, renal as well as CNS effects. Alcohol intolerance (antabus-like effect) can occur when cephalosporins containing the NMTT moiety are administered concomitantly. Cephalosporins with either a NMTT or a MTD (methylthiadiazole) moiety are linked with hypoprothrombinaemias.
引用
收藏
页码:S244 / S252
页数:9
相关论文
共 45 条
[1]  
Adam D, 1987, ALLGEMEINE SPEZIELLE, P580
[2]  
ANDRASSY K, 1985, ARZNEIMITTELTHERAPIE, V3, P66
[3]   CLINICAL PHARMACOKINETICS OF THE 3RD GENERATION CEPHALOSPORINS [J].
BALANT, L ;
DAYER, P ;
AUCKENTHALER, R .
CLINICAL PHARMACOKINETICS, 1985, 10 (02) :101-143
[4]  
BECHTOLD H, 1988, HAMOSTASEOLOGIE, V8, P8
[5]   PHARMACOKINETIC PROPERTIES OF THE CEPHALOSPORINS [J].
BERGAN, T .
DRUGS, 1987, 34 :89-104
[6]   COMPARATIVE PHARMACOKINETICS OF CEFAZOLIN, CEPHALOTHIN, CEPHACETRIL, AND CEPHAPIRINE AFTER INTRAVENOUS ADMINISTRATION [J].
BERGAN, T .
CHEMOTHERAPY, 1977, 23 (06) :389-404
[7]  
Brogard J M, 1982, Antibiot Chemother (1971), V31, P145
[8]   CLINICAL PHARMACOKINETICS OF CEFOTIAM [J].
BROGARD, JM ;
JEHL, F ;
WILLEMIN, B ;
LAMALLE, AM ;
BLICKLE, JF ;
MONTEIL, H .
CLINICAL PHARMACOKINETICS, 1989, 17 (03) :163-174
[9]   CEFOPERAZONE - A REVIEW OF ITS INVITRO ANTIMICROBIAL ACTIVITY, PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY [J].
BROGDEN, RN ;
CARMINE, A ;
HEEL, RC ;
MORLEY, PA ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1981, 22 (06) :423-460
[10]   CEFTRIAXONE - A REAPPRAISAL OF ITS ANTIBACTERIAL ACTIVITY AND PHARMACOKINETIC PROPERTIES, AND AN UPDATE ON ITS THERAPEUTIC USE WITH PARTICULAR REFERENCE TO ONCE-DAILY ADMINISTRATION [J].
BROGDEN, RN ;
WARD, A .
DRUGS, 1988, 35 (06) :604-645